Stenocare Current Ratio vs. Beta
| STENO Stock | DKK 2.04 0.14 7.37% |
For Stenocare profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Stenocare to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Stenocare AS utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Stenocare's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Stenocare AS over time as well as its relative position and ranking within its peers.
Stenocare |
Stenocare AS Beta vs. Current Ratio Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Stenocare's current stock value. Our valuation model uses many indicators to compare Stenocare value to that of its competitors to determine the firm's financial worth. Stenocare AS is rated below average in current ratio category among its peers. It also is rated below average in beta category among its peers totaling about 0.02 of Beta per Current Ratio. The ratio of Current Ratio to Beta for Stenocare AS is roughly 61.23 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Stenocare by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Stenocare's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Stenocare Beta vs. Current Ratio
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Stenocare |
| = | 6.49 X |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Stenocare |
| = | 0.11 |
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Stenocare Beta Comparison
Stenocare is rated below average in beta category among its peers.
Beta Analysis
As returns on the market increase, Stenocare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Stenocare is expected to be smaller as well.
Stenocare Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Stenocare, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Stenocare will eventually generate negative long term returns. The profitability progress is the general direction of Stenocare's change in net profit over the period of time. It can combine multiple indicators of Stenocare, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Stenocare AS cultivates, produces, imports, sells, and distributes prescription-based medical cannabis products in the Danish and European markets. The company was founded in 2017 and is headquartered in Allerd, Denmark. STENOCARE is traded on Copenhagen Stock Exchange in Denmark.
Stenocare Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Stenocare. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Stenocare position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Stenocare's important profitability drivers and their relationship over time.
Use Stenocare in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Stenocare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stenocare will appreciate offsetting losses from the drop in the long position's value.Stenocare Pair Trading
Stenocare AS Pair Trading Analysis
The ability to find closely correlated positions to Stenocare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Stenocare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Stenocare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Stenocare AS to buy it.
The correlation of Stenocare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Stenocare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Stenocare AS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Stenocare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Stenocare position
In addition to having Stenocare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run FinTech Thematic Idea Now
FinTech
High long term potential financial entities that are ranging from payment processing, investment management to commercial and investment banking. The FinTech theme has 81 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize FinTech Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Stenocare Stock
To fully project Stenocare's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Stenocare AS at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Stenocare's income statement, its balance sheet, and the statement of cash flows.